FDA approves new mifepristone drug label in major defeat for abortion foes
FDA approves new mifepristone drug label in major defeat for abortion foes
In a move that could sharply undercut efforts to limit abortion by medication, the US Food and Drug Administration on Wednesday announced that it had approved new labeling for the country’s most widely used abortion drug, mifepristone, to better reflect what scientific research shows is the most effective way to use the drug.
The fervor with which abortion opponents have pursued restrictions on mifepristone appears to contrast with the drug’s safety record. In 2011, the FDA
reported that
1.52 million women had used the drug since its approval, and only 612 experienced serious complications.